SG153877A1 - Treatment of cancer - Google Patents

Treatment of cancer

Info

Publication number
SG153877A1
SG153877A1 SG200904521-2A SG2009045212A SG153877A1 SG 153877 A1 SG153877 A1 SG 153877A1 SG 2009045212 A SG2009045212 A SG 2009045212A SG 153877 A1 SG153877 A1 SG 153877A1
Authority
SG
Singapore
Prior art keywords
cancer
treatment
hsp9o
leukaemia
preparations
Prior art date
Application number
SG200904521-2A
Inventor
James Peter Burnie
Ruth Christine Matthews
Tracey Carter
Original Assignee
Neutec Pharma Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0414885A external-priority patent/GB0414885D0/en
Priority claimed from GB0420845A external-priority patent/GB0420845D0/en
Priority claimed from GB0503566A external-priority patent/GB0503566D0/en
Application filed by Neutec Pharma Plc filed Critical Neutec Pharma Plc
Publication of SG153877A1 publication Critical patent/SG153877A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention relates to a novel medicaments and preparations comprising effective anti-cancer agents together with an anti-Hsp9O antibody which together provide an enhanced efficacy in the treatment of cancer, and leukaemia.
SG200904521-2A 2004-07-02 2005-06-30 Treatment of cancer SG153877A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0414885A GB0414885D0 (en) 2004-07-02 2004-07-02 Cancer therapy
GB0420845A GB0420845D0 (en) 2004-09-20 2004-09-20 Treatment of cancer
US61442304P 2004-09-30 2004-09-30
GB0503566A GB0503566D0 (en) 2005-02-21 2005-02-21 Treatment for cancer
US65445805P 2005-02-22 2005-02-22

Publications (1)

Publication Number Publication Date
SG153877A1 true SG153877A1 (en) 2009-07-29

Family

ID=39124615

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200904521-2A SG153877A1 (en) 2004-07-02 2005-06-30 Treatment of cancer

Country Status (8)

Country Link
JP (1) JP2008504355A (en)
BR (1) BRPI0512889A (en)
EC (1) ECSP077219A (en)
IL (1) IL180460A (en)
MA (1) MA28701B1 (en)
MX (1) MX2007000263A (en)
NZ (1) NZ552508A (en)
SG (1) SG153877A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0008305D0 (en) * 2000-04-06 2000-05-24 Neutec Pharma Plc Treatment of fungal infections

Also Published As

Publication number Publication date
MA28701B1 (en) 2007-06-01
MX2007000263A (en) 2007-07-20
BRPI0512889A (en) 2008-04-15
NZ552508A (en) 2009-10-30
IL180460A (en) 2010-12-30
ECSP077219A (en) 2007-03-29
IL180460A0 (en) 2007-06-03
JP2008504355A (en) 2008-02-14

Similar Documents

Publication Publication Date Title
UA105210C2 (en) Anti-cancer vaccine and use thereof
CA115590S (en) Back therapy device
CA119221S (en) Blister package
IL184617A0 (en) Dr5 antibodies and uses thereof
TW200612918A (en) Lonidamine analogs
EA200602047A1 (en) SULPHONYLETHYL PHOSPHORODYAMIDATES, INTENDED FOR USE IN CANCER TREATMENT
CA119341S (en) Goggle
TW200642682A (en) A combination of medical drugs to augment the anti-cancer effect of chemotherapy
TW200642684A (en) Anti-proliferative combination therapy using certain platinum-based chemotherapeutic agents and taxanes
WO2008010991A3 (en) Methods and compositions for the treatment of cancer
MX2008001597A (en) Novel formulations comprising fenofibrate and a statin, and related methods of treatment.
IL163902A0 (en) Antibodies against cancer antigen tmeff2 and uses thereof
LU92203I9 (en)
UA99601C2 (en) Use of an anti-cd151 antibody in the treatment of cancer
HK1076055A1 (en) Covalent conjugates between artemisinin-related endoperoxides and iron- carrying proteins and methods of use
EP1503748A4 (en) Drugs for mitigating taxane-induced neurotoxicity
EA200970353A1 (en) COMBINED MEDICINE
CA119778S (en) Package
PL1869185T3 (en) Conjugate comprising p21 protein for the treatment of cancer
PT1713438E (en) Medicinal soap
CA105215S (en) Packaging with cosmetic composition
CA117351S (en) Iron
CA119697S (en) Loudspeaker housing
WO2007007152A3 (en) Anti-madcam antibodies to treat metastatic cancers and chloroma
GB0111628D0 (en) Binding member